{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-000971","form_type":"8-K","ticker":"PETV","cik":"0001512922","company_name":"PetVivo Holdings, Inc.","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.330663+00:00","generated_at":"2026-06-20T17:45:35.396403+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PetVivo enters registered direct offering of 575,011 shares at $2.32/share for ~$1.3M net proceeds","bullets":["Sold 575,011 common shares at $2.32 per share in a registered direct offering to accredited investors.","Estimated net proceeds of approximately $1.3 million after transaction expenses.","Net proceeds to fund commercialization of Spryng™ with OsteoCushion™ Technology and clinical trials.","Offering expected to close on January 9, 2023; no placement agent or underwriter involved.","Shares issued directly to purchasers under a prospectus supplement dated January 6, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-000971","json":"https://secwatch.observer/filing/0001493152-23-000971.json","markdown":"https://secwatch.observer/filing/0001493152-23-000971.md","text":"https://secwatch.observer/filing/0001493152-23-000971.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512922/000149315223000971/0001493152-23-000971-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512922/000149315223000971/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:45:35.396403+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"60c127afc812b76fdac40554dfbad6fb9e790b30","claim":"PetVivo Holdings, Inc. entered into Purchase Agreement with certain accredited investors valued at approximately $1.3 million (effective 2023-01-05).","evidence_excerpt":"On January 5, 2023, PetVivo Holdings, Inc. (the “Company”) entered into a securities purchase agreement with certain accredited investors (the “Purchase Agreement”), pursuant to which the Company agreed to sell and issue an aggregate of 575,011 shares of its common stock (the “Registered Shares”) in a registered direct offering (the “Registered Offering”) of the Company’s common stock (the “Common Stock”) at a purchase price of $2.32 per share.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1512922/000149315223000971/0001493152-23-000971-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"approximately $1.3 million"},{"label":"Effective","value":"2023-01-05"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}